| Name | 2-(4-methoxyphenyl)-1,6,7,8,9,10-hexahydrocyclohepta[b]pyrazolo[3,4-d]pyridin-3(2h)-one |
|---|
| Description | CGS 20625 is a potent, selective and orally active partial agonist for the central benzodiazepine receptor. CGS 20625 inhibits [3H]-flunitrazepam binding to central benzodiazepine receptors with an IC50 of 1.3 nM. CGS 20625 can be used for the research of pentylenetetrazol-induced seizures[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.3 nM ([3H]-flunitrazepam binding to central benzodiazepine receptors)[1] |
| References |
| Density | 1.246g/cm3 |
|---|---|
| Boiling Point | 503.8ºC at 760mmHg |
| Molecular Formula | C18H19N3O2 |
| Molecular Weight | 309.36 |
| Flash Point | 258.5ºC |
| Exact Mass | 309.14800 |
| PSA | 59.91000 |
| LogP | 2.99130 |
| Vapour Pressure | 2.82E-10mmHg at 25°C |
| Index of Refraction | 1.617 |